Scandion Oncology A/S (OSTO:SCOL) Accounts Payable : kr3.12 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Scandion Oncology A/S Accounts Payable?

Scandion Oncology A/S's Accounts Payable for the quarter that ended in Mar. 2024 was kr3.12 Mil.

Scandion Oncology A/S's quarterly Accounts Payable declined from Sep. 2023 (kr4.77 Mil) to Dec. 2023 (kr2.07 Mil) but then increased from Dec. 2023 (kr2.07 Mil) to Mar. 2024 (kr3.12 Mil).

Scandion Oncology A/S's annual Accounts Payable increased from Dec. 2021 (kr6.33 Mil) to Dec. 2022 (kr7.23 Mil) but then declined from Dec. 2022 (kr7.23 Mil) to Dec. 2023 (kr2.07 Mil).

Scandion Oncology A/S Accounts Payable Historical Data

The historical data trend for Scandion Oncology A/S's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scandion Oncology A/S Accounts Payable Chart

Scandion Oncology A/S Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

1.35

35.64

6.33

7.23

2.07

Scandion Oncology A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															3.86	3.70	4.77	2.07	3.12

Scandion Oncology A/S Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Scandion Oncology A/S Accounts Payable Related Terms

Thank you for viewing the detailed overview of Scandion Oncology A/S's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Scandion Oncology A/S (OSTO:SCOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandion Oncology A/S (OSTO:SCOL) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

8VY:Germany

Address

Fruebjergvej 3, Symbion, Copenhagen, DNK, 2100

Website

https://www.scandiononcology.com

Scandion Oncology A/S is a clinical-stage biotechnology company developing first-in-class medicines aimed at treating cancer that is resistant to current treatment options. Cancer Drug Resistance Company discovers and develops first-in-class medicines aimed at treating cancer that is resistant to current treatment options.

Scandion Oncology A/S (OSTO:SCOL) Headlines

No Headlines